Post

New research · Ophthalmology
The British journal of ophthalmology · 12h
ObservationalThe British journal of ophthalmology · 2026

Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation-specific risk.

Moiz Lakhani, Abdullah Al-Ani, Marko Popovic … Edward Margolin
Read paper
OphthalmologyObservational

Wegovy is associated with nearly 5-fold higher odds of ischemic optic neuropathy than Ozempic.

Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation-specific risk.

Moiz Lakhani … Edward Margolin
The British journal of ophthalmology · 2026
Background

Ischaemic optic neuropathy (ischaemic optic neuropathy) is a rare but vision-threatening complication recently linked to GLP-1 receptor agonists, particularly semaglutide.

Methods

Using over 30 million reports from the FDA Adverse Event Reporting System (2017-2024), we evaluated formulation- and sex-specific associations.

n = 31 774
AOR 4.74
Results
AOR 4.74
Odds of ischemic optic neuropathy were nearly 5 times higher with Wegovy than Ozempic.
n = 31 774
More results

Among 31 774 semaglutide cases, Wegovy demonstrated the strongest signal for ischaemic optic neuropathy (reporting odds ratio (reporting odds ratio)=74.89) compared with Ozempic (reporting odds ratio=18.81).

“
Conclusion

These findings highlight a potential dose-dependent safety concern that warrants urgent prospective evaluation to guide prescribing and regulatory policy.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment